Tandospirone augmentation of paroxetine in agitated depression

被引：0

作者：

Hirabayashi, E ^{[1
]}

Okada, S ^{[1
]}

Yamate, T ^{[1
]}

Kaneko, M ^{[1
]}

Iimori, M ^{[1
]}

机构：

[1] Tokyo Med Univ Hosp, Tokyo, Japan

来源：

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2004年 / 7卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：S344 / S344

页数：1

共 50 条

[41] NEUROCHEMISTRY AND PAROXETINE RESPONSE IN MAJOR DEPRESSION
GOODNICK, PJ
HENRY, J
KUMAR, A
BIOLOGICAL PSYCHIATRY, 1995, 37 (06) : 417 - 419
[42] Paroxetine in the treatment of depression with associated anxiety
Neumeister, A
NEUROPSYCHIATRIE, 2001, 15 (01) : 18 - 24
[43] Superiority of escitalopram to paroxetine in the treatment of depression
Kasper, Siegfried
Baldwin, David S.
Lonn, Sara Larsson
Boulenger, Jean-Philippe
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 (04) : 229 - 237
[44] Paroxetine for the treatment of depression: a critical update
Gibiino, Sara
Serretti, Alessandro
EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (03) : 421 - 431
[45] Pharmacological treatment of depression: the role of paroxetine
Deahl, M
HOSPITAL MEDICINE, 2001, 62 (01): : 38 - 42
[46] PAROXETINE IN THE TREATMENT OF MELANCHOLIA AND SEVERE DEPRESSION
TIGNOL, J
STOKER, MJ
DUNBAR, GC
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1992, 7 (02) : 91 - 94
[47] Effectiveness of paroxetine in the treatment of poststroke depression
Ma, Chen
Li, Ping
MEDICINE, 2018, 97 (29)
[48] Clinical efficacy of tandospirone augmentation in patients with major depressive disorder: A randomized controlled trial
Yamada, K
Yagi, G
Kanba, S
PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2003, 57 (02) : 183 - 187
[49] Activated Depression: Mixed Bipolar Disorder or Agitated Unipolar Depression?
Swann, Alan C.
CURRENT PSYCHIATRY REPORTS, 2013, 15 (08)
[50] Activated Depression: Mixed Bipolar Disorder or Agitated Unipolar Depression?
Alan C. Swann
Current Psychiatry Reports, 2013, 15

← 1 2 3 4 5 →